3/1/2021 2:32:40 PM
Read about our growing drug portfolio that focuses
Read about our growing drug portfolio that focuses on the treatment of four main cancer types including: prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL). The AIkido Pharma Inc. platform contains patented technology from leading universities and researchers and we seek to develop our innovative drugs through strong partnership with world renowned institutions, such as The University of Texas and Wake Forest University. For more information, visit us online or call us at 212-745-1373.
-
Meet Aikido Pharma A BioTechnology Development Company Focused on The Treatment Of Early and Mid-Stage Small-Molecule Anti-Cancer Therapeutics
2/28/2021 4:30:00 AM
2/28/2021 2:30:00 AM
2/28/2021 1:30:00 AM
2/28/2021 12:30:00 AM
2/27/2021 9:30:00 PM
2/27/2021 4:30:00 AM
2/27/2021 2:30:00 AM
2/27/2021 1:30:00 AM
2/27/2021 12:30:00 AM
2/26/2021 10:30:00 PM
2/26/2021 9:30:00 PM
2/26/2021 4:30:00 AM
2/26/2021 1:30:00 AM
2/26/2021 1:00:00 AM
Report This Post
Please complete the following requested information to flag this post and report abuse, or offensive content. Your report will be reviewed within 24 hours. We will take appropriate action as described in Findit terms of use.
